866-997-4948(US-Canada Toll Free)

Global Human Rotavirus Vaccine Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 118 Pages

This report studies the global market size of Human Rotavirus Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Rotavirus Vaccine in these regions.
This research report categorizes the global Human Rotavirus Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.
In 2017, the global Human Rotavirus Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Human Rotavirus Vaccine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Human Rotavirus Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Human Rotavirus Vaccine include
Bharat Biotech
Merck
GlaxoSmithKline

Market Size Split by Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Market Size Split by Application
Hospitals & Clinics
Academic And Research
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Human Rotavirus Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Human Rotavirus Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Human Rotavirus Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Rotavirus Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Human Rotavirus Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Human Rotavirus Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Rotavirus Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Human Rotavirus Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Human Rotavirus Vaccine Market Size Growth Rate by Type
1.4.2 Rotarix
1.4.3 RotaTeq
1.4.4 Rotavac
1.4.5 Rotavin-M1
1.4.6 Lanzhou lamb
1.4.7 Others
1.5 Market by Application
1.5.1 Global Human Rotavirus Vaccine Market Size Growth Rate by Application
1.5.2 Hospitals & Clinics
1.5.3 Academic And Research
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Human Rotavirus Vaccine Market Size
2.1.1 Global Human Rotavirus Vaccine Revenue 2016-2025
2.1.2 Global Human Rotavirus Vaccine Sales 2016-2025
2.2 Human Rotavirus Vaccine Growth Rate by Regions
2.2.1 Global Human Rotavirus Vaccine Sales by Regions
2.2.2 Global Human Rotavirus Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Human Rotavirus Vaccine Sales by Manufacturers
3.1.1 Human Rotavirus Vaccine Sales by Manufacturers
3.1.2 Human Rotavirus Vaccine Sales Market Share by Manufacturers
3.1.3 Global Human Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Human Rotavirus Vaccine Revenue by Manufacturers
3.2.1 Human Rotavirus Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Human Rotavirus Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Human Rotavirus Vaccine Price by Manufacturers
3.4 Human Rotavirus Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Human Rotavirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Rotavirus Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Human Rotavirus Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Human Rotavirus Vaccine Sales by Type
4.2 Global Human Rotavirus Vaccine Revenue by Type
4.3 Human Rotavirus Vaccine Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Human Rotavirus Vaccine Breakdown Data by Application

6 North America
6.1 North America Human Rotavirus Vaccine by Countries
6.1.1 North America Human Rotavirus Vaccine Sales by Countries
6.1.2 North America Human Rotavirus Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Human Rotavirus Vaccine by Type
6.3 North America Human Rotavirus Vaccine by Application
6.4 North America Human Rotavirus Vaccine by Company

7 Europe
7.1 Europe Human Rotavirus Vaccine by Countries
7.1.1 Europe Human Rotavirus Vaccine Sales by Countries
7.1.2 Europe Human Rotavirus Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Rotavirus Vaccine by Type
7.3 Europe Human Rotavirus Vaccine by Application
7.4 Europe Human Rotavirus Vaccine by Company

8 Asia Pacific
8.1 Asia Pacific Human Rotavirus Vaccine by Countries
8.1.1 Asia Pacific Human Rotavirus Vaccine Sales by Countries
8.1.2 Asia Pacific Human Rotavirus Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Human Rotavirus Vaccine by Type
8.3 Asia Pacific Human Rotavirus Vaccine by Application
8.4 Asia Pacific Human Rotavirus Vaccine by Company

9 Central & South America
9.1 Central & South America Human Rotavirus Vaccine by Countries
9.1.1 Central & South America Human Rotavirus Vaccine Sales by Countries
9.1.2 Central & South America Human Rotavirus Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Human Rotavirus Vaccine by Type
9.3 Central & South America Human Rotavirus Vaccine by Application
9.4 Central & South America Human Rotavirus Vaccine by Company

10 Middle East and Africa
10.1 Middle East and Africa Human Rotavirus Vaccine by Countries
10.1.1 Middle East and Africa Human Rotavirus Vaccine Sales by Countries
10.1.2 Middle East and Africa Human Rotavirus Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Human Rotavirus Vaccine by Type
10.3 Middle East and Africa Human Rotavirus Vaccine by Application
10.4 Middle East and Africa Human Rotavirus Vaccine by Company

11 Company Profiles
11.1 Bharat Biotech
11.1.1 Bharat Biotech Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Human Rotavirus Vaccine
11.1.4 Human Rotavirus Vaccine Product Description
11.1.5 Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Human Rotavirus Vaccine
11.2.4 Human Rotavirus Vaccine Product Description
11.2.5 Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Human Rotavirus Vaccine
11.3.4 Human Rotavirus Vaccine Product Description
11.3.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Human Rotavirus Vaccine Raw Material
13.1.2 Human Rotavirus Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Human Rotavirus Vaccine
Figure Global Human Rotavirus Vaccine Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Human Rotavirus Vaccine Production Market Share by Types (Product Category) in 2017
Figure Rotarix Product Picture
Table Major Manufacturers of Rotarix
Figure RotaTeq Product Picture
Table Major Manufacturers of RotaTeq
Figure Rotavac Product Picture
Table Major Manufacturers of Rotavac
Figure Rotavin-M1 Product Picture
Table Major Manufacturers of Rotavin-M1
Figure Lanzhou lamb Product Picture
Table Major Manufacturers of Lanzhou lamb
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Human Rotavirus Vaccine Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospitals & Clinics
Figure Academic And Research
Figure Others
Figure Human Rotavirus Vaccine Report Years Considered
Figure Global Human Rotavirus Vaccine Market Size 2016-2025 (Million US$)
Figure Global Human Rotavirus Vaccine Sales 2016-2025 (K Units)
Table Global Human Rotavirus Vaccine Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Human Rotavirus Vaccine Sales by Regions 2016-2025 (K Units)
Table Global Human Rotavirus Vaccine Sales Market Share by Regions 2016-2025
Figure Global Human Rotavirus Vaccine Sales Market Share by Regions 2016-2025
Figure 2017 Global Human Rotavirus Vaccine Sales Market Share by Regions
Table Global Human Rotavirus Vaccine Revenue by Regions 2016-2025 (Million US$)
Table Global Human Rotavirus Vaccine Revenue Market Share by Regions 2016-2025
Figure Global Human Rotavirus Vaccine Revenue Market Share by Regions 2016-2025
Figure 2017 Global Human Rotavirus Vaccine Revenue Market Share by Regions
Table Global Human Rotavirus Vaccine Sales by Manufacturers (2016-2018) (K Units)
Table Global Human Rotavirus Vaccine Sales Share by Manufacturers (2016-2018)
Figure Global Human Rotavirus Vaccine Sales Share by Manufacturers in 2017
Table Human Rotavirus Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
Table Human Rotavirus Vaccine Revenue Share by Manufacturers (2016-2018)
Figure Human Rotavirus Vaccine Value Share by Manufacturers in 2017
Table Global Human Rotavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Human Rotavirus Vaccine Price (2016-2018) (USD/Unit)
Table Human Rotavirus Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Human Rotavirus Vaccine Product Category
Table Date of International Manufacturers Enter into Human Rotavirus Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Human Rotavirus Vaccine Sales by Type (2016-2025) (K Units)
Table Global Human Rotavirus Vaccine Sales Share by Type (2016-2025)
Figure Global Human Rotavirus Vaccine Sales Market Share by Type (2016-2025)
Figure Global Human Rotavirus Vaccine Sales Market Share by Type in 2017
Table Global Human Rotavirus Vaccine Revenue by Type (2016-2025) (Million US$)
Table Global Human Rotavirus Vaccine Revenue Share by Type (2016-2025)
Figure Global Human Rotavirus Vaccine Revenue Market Share by Type (2016-2025)
Figure Global Human Rotavirus Vaccine Revenue Market Share by Type in 2017
Table Human Rotavirus Vaccine Price by Type 2013-2018 (USD/Unit)
Table Global Human Rotavirus Vaccine Sales by Application (2016-2025) (K Units)
Table Global Human Rotavirus Vaccine Sales Share by Application (2016-2025)
Figure Global Sales Human Rotavirus Vaccine Market Share by Application (2016-2025)
Figure Global Sales Human Rotavirus Vaccine Market Share by Application (2016-2025)
Figure North America Human Rotavirus Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure North America Human Rotavirus Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table North America Human Rotavirus Vaccine Sales by Countries (2016-2025) (K Units)
Table North America Human Rotavirus Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 North America Human Rotavirus Vaccine Sales Market Share by Countries
Table North America Human Rotavirus Vaccine Revenue by Countries (2016-2025) (Million US$)
Table North America Human Rotavirus Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Human Rotavirus Vaccine Revenue Market Share by Countries
Figure United States Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure United States Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Canada Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table North America Human Rotavirus Vaccine Sales by Type (2016-2025) (K Units)
Table North America Human Rotavirus Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 North America Human Rotavirus Vaccine Market Share by Type
Table North America Human Rotavirus Vaccine Sales by Application (2016-2025) (K Units)
Table North America Human Rotavirus Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 North America Human Rotavirus Vaccine Market Share by Application
Table North America Human Rotavirus Vaccine Sales by Company (2016-2018) (K Units)
Table North America Human Rotavirus Vaccine Sales Market Share by Company (2016-2018)
Figure North America Human Rotavirus Vaccine Sales Market Share by Company in 2017
Figure Europe Human Rotavirus Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure Europe Human Rotavirus Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Human Rotavirus Vaccine Sales by Countries (2016-2025) (K Units)
Table Europe Human Rotavirus Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Human Rotavirus Vaccine Sales Market Share by Countries
Table Europe Human Rotavirus Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Europe Human Rotavirus Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Human Rotavirus Vaccine Revenue Market Share by Countries
Figure Germany Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Germany Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (K Units)
Figure France Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure France Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (K Units)
Figure UK Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure UK Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Italy Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Russia Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Human Rotavirus Vaccine Sales by Type (2016-2025) (K Units)
Table Europe Human Rotavirus Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Europe Human Rotavirus Vaccine Market Share by Type
Table Europe Human Rotavirus Vaccine Sales by Application (2016-2025) (K Units)
Table Europe Human Rotavirus Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Europe Human Rotavirus Vaccine Market Share by Application
Table Europe Human Rotavirus Vaccine Sales by Company (2016-2018) (K Units)
Table Europe Human Rotavirus Vaccine Sales Market Share by Company (2016-2018)
Figure Europe Human Rotavirus Vaccine Sales Market Share by Company in 2017
Figure Asia Pacific Human Rotavirus Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Human Rotavirus Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Human Rotavirus Vaccine Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Human Rotavirus Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Human Rotavirus Vaccine Sales Market Share by Countries
Table Asia Pacific Human Rotavirus Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Human Rotavirus Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Human Rotavirus Vaccine Revenue Market Share by Countries
Figure China Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure China Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Japan Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Korea Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure India Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure India Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Australia Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Human Rotavirus Vaccine Sales by Type (2016-2025) (K Units)
Table Asia Pacific Human Rotavirus Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Human Rotavirus Vaccine Market Share by Type
Table Asia Pacific Human Rotavirus Vaccine Sales by Application (2016-2025) (K Units)
Table Asia Pacific Human Rotavirus Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Human Rotavirus Vaccine Market Share by Application
Table Asia Pacific Human Rotavirus Vaccine Sales by Company (2016-2018) (K Units)
Table Asia Pacific Human Rotavirus Vaccine Sales Market Share by Company (2016-2018)
Figure Asia Pacific Human Rotavirus Vaccine Sales Market Share by Company in 2017
Figure Central & South America Human Rotavirus Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Human Rotavirus Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Human Rotavirus Vaccine Sales by Countries (2016-2025) (K Units)
Table Central & South America Human Rotavirus Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Human Rotavirus Vaccine Sales Market Share by Countries
Table Central & South America Human Rotavirus Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Human Rotavirus Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Human Rotavirus Vaccine Revenue Market Share by Countries
Figure Brazil Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Human Rotavirus Vaccine Sales by Type (2016-2025) (K Units)
Table Central & South America Human Rotavirus Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Human Rotavirus Vaccine Market Share by Type
Table Central & South America Human Rotavirus Vaccine Sales by Application (2016-2025) (K Units)
Table Central & South America Human Rotavirus Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Human Rotavirus Vaccine Market Share by Application
Table Central & South America Human Rotavirus Vaccine Sales by Company (2016-2018) (K Units)
Table Central & South America Human Rotavirus Vaccine Sales Market Share by Company (2016-2018)
Figure Central & South America Human Rotavirus Vaccine Sales Market Share by Company in 2017
Figure Middle East and Africa Human Rotavirus Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Human Rotavirus Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Human Rotavirus Vaccine Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Countries
Table Middle East and Africa Human Rotavirus Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Human Rotavirus Vaccine Revenue Market Share by Countries
Figure GCC Countries Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Human Rotavirus Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Human Rotavirus Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Human Rotavirus Vaccine Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Human Rotavirus Vaccine Market Share by Type
Table Middle East and Africa Human Rotavirus Vaccine Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Human Rotavirus Vaccine Market Share by Application
Table Middle East and Africa Human Rotavirus Vaccine Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Company in 2017
Table Bharat Biotech Company Details
Table Bharat Biotech Human Rotavirus Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bharat Biotech Recent Development
Table Merck Company Details
Table Merck Human Rotavirus Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Human Rotavirus Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Human Rotavirus Vaccine Value Chain
Table Typical Suppliers of Key Human Rotavirus Vaccine Raw Material
Table Human Rotavirus Vaccine Customers List
Table Human Rotavirus Vaccine Sales Channels
Table Human Rotavirus Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *